Hers vs IVIM Health: Wegovy vs Compounded GLP-1 Options
Hers vs IVIM Health compare two telehealth weight loss options with different product types, pricing models, and program claims. Early verdict: choose Hers for access to FDA-approved brand-name Wegovy® and no compounded medications; choose IVIM Health if lower starting price, compounded formulas, and a clinician-guided GLP-1 optimization protocol matter more to you.
See Hers Wegovy® pricing and membership
What separates Hers and IVIM Health
The most distinctive differences are product type and regulatory status, starting price and membership structure, third-party satisfaction and program claims, and dosing protocol and ongoing support. These differences drive cost, perceived safety, and the type of clinical oversight you can expect.
1. Product type and regulatory status
Hers offers brand-name Wegovy® which the source states is FDA-approved and not a compounded medication. IVIM Health provides compounded semaglutide and tirzepatide formulations, and the source emphasizes that compounded drugs are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. Both sources note prescriptions and clinician review are required where applicable. This is a core practical and regulatory distinction between the two providers.
2. Pricing and membership details
Hers lists Wegovy® pill pricing from $149/mo and injectable options from $199/mo, but the source also states an active Hers Weight Loss Membership is required with a $39 first month and auto-renews at $149/month thereafter. The Hers source cautions total cost includes membership and medication and that a prescription is not guaranteed. IVIM Health lists compounded semaglutide at $75/mo, tirzepatide at $133/mo, plus a $74.99/mo program fee in some materials, and states a promotional free month membership code GIFT75 and a no-obligation free consultation valued at $75. IVIM’s FAQ notes a first-month price of $99 and ongoing $174/month in other captured text. The comparison shows Hers emphasizes branded FDA-approved options and membership requirement while IVIM emphasizes lower starting costs and promotional codes but also notes ongoing fees.
3. Third-party validation and program claims
IVIM Health highlights a 4.9-star rating on both Google and Trustpilot and cites proprietary protocol claims, including a claim that the IVIM Protocol can accelerate weight loss outcomes by up to 40% or that patients lost an average of 46% more weight in their published observational data over 68 weeks. The source explicitly states these are not head-to-head trials and the 40% figure is IVIM’s protocol claim, not an independent clinical finding. Hers emphasizes FDA-approved brand-name options and personalized care teams with ongoing dose check-ins but does not provide the third-party rating signal captured for IVIM.
4. Dosing, clinician oversight, and program structure
Both providers operate with clinician evaluation and prescriptions where appropriate. Hers advertises personalized care teams and ongoing dose check-ins for its brand-name GLP-1 offerings. IVIM describes a clinician-guided GLP-1 ID protocol with weekly dose adjustments and a structured optimization approach, and notes that compounded medications are prescribed after consultation and used under ongoing supervision. The sources show both provide clinician oversight but IVIM markets a proprietary optimization protocol as a differentiator while Hers emphasizes FDA-approved medications and personalized care check-ins.
| Criteria | Hers | IVIM Health |
|---|---|---|
| Product type | FDA-approved Wegovy®, not compounded | Compounded semaglutide and tirzepatide |
| Starting price | Wegovy® pill from $149/mo; injectable from $199/mo | Compounded semaglutide from $75/mo; other pricing shows $99 first month then $174/mo ongoing |
| Membership / fees | Active membership required; $39 first month then auto-renews at $149/mo per source | Free month code GIFT75 and free consult; program fee referenced at $74.99/mo; ongoing pricing cited at $174/mo |
| Regulatory note | Name-brand FDA-approved product; no compounded meds | Compounded meds not FDA-reviewed; source warns they carry risks |
| Third-party validation | No dual 4.9-star claim captured | 4.9 stars on Google and Trustpilot per source |
| Program claims | Personalized care team and ongoing dose check-ins | Proprietary GLP-1 ID protocol claiming up to 40% faster results; published observational data cited |
Try IVIM free consult and use code GIFT75
How these differences affect your choice
If FDA approval and branded medication status are your top priorities, Hers provides Wegovy® that the source identifies as FDA-approved and not compounded, plus a named membership structure and ongoing dose check-ins. If lower upfront pricing, promotional free-month access, and strong third-party review signals matter more, IVIM Health advertises compounded options from $75/mo, a free consultation, a free month code GIFT75, and 4.9-star ratings on both Google and Trustpilot.
Learn about Hers membership and Wegovy®
Safety and evidence notes to consider
Both sources state prescriptions are required when clinically appropriate and clinician review determines eligibility. The providers differ on product status: Hers reiterates that its Wegovy® offering is a brand-name, FDA-approved product and not compounded. IVIM repeatedly notes its compounded medications are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality, and that their protocol results are based on observational data and not randomized head-to-head trials. The captured evidence does not supply independent comparative efficacy results between the two providers.
See IVIM pricing and protocol details
Conclusion: Choose based on product type, cost, and trust signals
Hers vs IVIM Health centers on whether you prefer FDA-approved brand medication and an explicit membership requirement with ongoing dose check-ins, or lower starting compounded pricing, promotional access, and strong third-party satisfaction signals with a proprietary optimization protocol. Use the points above to match the provider to your priorities.
Choose Hers if you want access to FDA-approved Wegovy® brand-name semaglutide, prefer no compounded medications, and accept a membership requirement and branded pricing structure.
Choose IVIM Health if you prefer lower starting monthly costs and promotional access, want a no-obligation free consultation and a free-month code GIFT75, and value IVIM’s dual 4.9-star external ratings and proprietary clinician-guided GLP-1 ID protocol.